Literature DB >> 22431190

Interleukin 6 protects H(2)O(2)-induced cardiomyocytes injury through upregulation of prohibitin via STAT3 phosphorylation.

Yuhua Jia1, Fenghua Zhou, Peng Deng, Qin Fan, Chunhua Li, Yawei Liu, Xiuqiong Fu, Yingchun Zhou, Xin Xu, Xuegang Sun.   

Abstract

OBJECTIVE: Hydrogen peroxide (H(2)O(2)) is a potent reactive oxygen species that causes cardiomyocytes injury. As an important cytokine, interleukin 6 (IL-6) has cardioprotective effects as it plays an essential role in the late phase of preconditioning. Our work is to investigate if IL-6 preconditioning has protective effects on neonatal rat ventricular cardiomyocytes in response to H(2)O(2) and its underlying mechanism.
METHODS: Gel-based comparative proteomic approach along with small interfering RNA (siRNA) and Western blot analysis was used to analyse mechanisms of IL-6 preconditioning on H(2)O(2)-induced neonatal rat ventricular cardiomyocytes injury.
RESULTS: IL-6 preconditioning protected cardiomyocytes against H(2)O(2)-induced cell death. Proteomic analysis showed that IL-6 pretreatment further increased the expression of prohibitin and improved the viability of cardiomyocytes exposed to H(2)O(2). Knocking down of prohibitin with siRNA abrogated this protection by increasing apoptosis rate. Tyrosine kinase inhibitor AG490 decreased signal transducers and activators of transcription 3 (STAT3) phosphorylation and down-regulated prohibitin expression in cardiomyocytes pretreated with IL-6 and exposed to H(2)O(2), which further dampened the protective effects of IL-6 preconditioning.
CONCLUSION: Our results provide direct evidence that prohibitin is a protective factor of IL-6 preconditioning in H(2)O(2)-induced neonatal rat ventricular cardiomyocytes death. The upregulation of prohibitin by IL-6 is, at least, partially regulated through STAT3 phosphorylation.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431190     DOI: 10.1002/cbf.2820

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  6 in total

Review 1.  Role of interleukin-6 in cancer progression and therapeutic resistance.

Authors:  Neeraj Kumari; B S Dwarakanath; Asmita Das; Anant Narayan Bhatt
Journal:  Tumour Biol       Date:  2016-06-03

2.  Prohibitin 1 modulates mitochondrial function of Stat3.

Authors:  Jie Han; Chunhua Yu; Rhonda F Souza; Arianne L Theiss
Journal:  Cell Signal       Date:  2014-06-26       Impact factor: 4.315

3.  Apigenin Attenuates Atherogenesis through Inducing Macrophage Apoptosis via Inhibition of AKT Ser473 Phosphorylation and Downregulation of Plasminogen Activator Inhibitor-2.

Authors:  Ping Zeng; Bin Liu; Qun Wang; Qin Fan; Jian-Xin Diao; Jing Tang; Xiu-Qiong Fu; Xue-Gang Sun
Journal:  Oxid Med Cell Longev       Date:  2015-04-15       Impact factor: 6.543

4.  The Potential Role of Cytokines in Diabetic Intervertebral Disc Degeneration.

Authors:  Sunlong Li; Chongan Huang; Jian Xiao; Yuhao Wu; Zengjie Zhang; Yifei Zhou; Naifeng Tian; Yaosen Wu; Xiangyang Wang; Xiaolei Zhang
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

5.  FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.

Authors:  Rehana Qureshi; Onur Yildirim; Adeline Gasser; Christine Basmadjian; Qian Zhao; Jean-Philippe Wilmet; Laurent Désaubry; Canan G Nebigil
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

Review 6.  Prohibitin: a potential therapeutic target in tyrosine kinase signaling.

Authors:  Sudharsana Rao Ande; Yang Xin Zi Xu; Suresh Mishra
Journal:  Signal Transduct Target Ther       Date:  2017-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.